Accomplished leader skilled in strategic positioning, team building, change management, and developing an environment of entrepreneurial esprit de corps. Collaborative and entrepreneurial management style with a track record of creating shared vision, driving operational success, and capitalizing on emerging business opportunities. Success at the executive level in organizational development, business positioning, new business start-up, and managing exponential growth. History of providing breakthrough leadership to achieve corporate strategies. Extensive experience with C-Level decision makers in healthcare and environmental industries. Extensive laboratory sales and marketing experience, with an emphasis on laboratory testing and technical consulting services.

Seeking to apply highly developed interpersonal skills and a straight forward, empathetic communication style to lead cross functional teams in a high growth business, ranging from start-up to small/midsize company. Key value proposition includes…

• Visionary Leadership – Provided leadership and technical insight from start-up through rocket propelled growth phase, creating a culture of employee engagement and shared vision as the company expanded nationally and exceeded $120MM in annual revenue.

• Operational Excellence – Systematically improved efficiency and quality to achieve industry leading annual revenue in excess of $300,000 per employee (more than 2X the industry benchmark).

• Growth Management – Repeatedly managed company resources to cope with rapid growth and expansion while simultaneously improving efficiency. As Division Manager (1999 – 2001), reduced headcount by 25% during a doubling of division revenues; as COO (2011 – 2012), presided over the transition from bootstrapped start-up to a dynamic high growth engine, adding infrastructure to ensure quality, customer service, facility, and IT support to maximize growth potential.

• Business Positioning and Business Development – Track record of differentiating companies as preferred providers in high profit niches, positioning the business for growth, profitability, and favorable re-capitalization with substantial earn-out to the principals.

Strengths that Impact Performance

• Business Analysis and Positioning

• Business Process Outsourcing

• Executive Leadership

• Laboratory Information Systems

• Operations Management

• Strategic Planning and Execution

• Business Development

• Corporate Vision and Culture

• Healthcare Billing & Compliance

• Laboratory Management

• Project Management

• Technical Insight

• Business Process Improvement

• Customer Service

• Entrepreneurial Drive

• Mentoring and Coaching

• Quality Systems

• Team Building and Alignment

Education and Training

B.S. in Biology, GEORGETOWN UNIVERSITY, WASHINGTON D.C.

Mastering Leadership Dynamics, BB&T LEADERSHIP INSTITUTE, GREENSBORO NC

Creating Value through Shared Vision and Culture

PHYSICIANS CHOICE LABORATORY SERVICES, CHARLOTTE NC 2009 – 2016

The company provided specialized analytical testing to clinicians and hospitals in support of narcotic prescription monitoring, opioid addiction therapy, heart health programs, women's health programs and personalized medicine. Testing services included mass spectrometry drug testing, clinical chemistry, cytology, and genetics. R&D activity included biomarker discovery to improve patient outcomes with bladder cancer. The laboratory grew from a start-up operation to more than $100MM in revenue and 450 employees over a five year span.

DIRECTOR OF STRATEGIC ASSETS 2016

PRESIDENT AND CHIEF EXECUTIVE OFFICER 2013 – 2015

CHIEF OPERATING OFFICER 2011 – 2012

CO-FOUNDER 2009

As Co-Founder, directed assay development and validation, quality assurance procedures, clinical laboratory licensure, and start-up of business operations. As an executive officer, conceived and implement strategic growth plans resulting in rapid expansion from a small local laboratory to a top 5 national laboratory.

Selected Accomplishments

• Oversight and leadership from conception to launch to expansion of a national clinical laboratory providing compliance drug monitoring services to physicians and behavioral health professionals, employing 450 employees and generating more than $120MM in annual revenue.

• Devised business positioning strategy to target disease state management in the areas of women’s health, neonatal health, cardiology, molecular diagnostics, and infectious disease to diversify service offerings and more efficiently penetrate payer networks.

• Spearheaded the acquisition, improvement, and commercialization strategy of a molecular diagnostic asset targeting improved outcomes in bladder cancer (test is currently in clinical trial).

Results

• 170% CAGR (2009 – 2014)

• 450 direct employees under management

• Top 5 Toxicology Laboratory in the US

COLUMBIA ANALYTICAL SERVICES, KELSO, WA 1992 – 2003; 2010 - 2011

The company provides specialized analytical testing to environmental engineers and government agencies with a network of laboratories strategically located throughout the United States. The company now operates under the ALS banner after an acquisition in 2012.

VP SALES AND MARKETING / MANAGER OF STRATEGIC MARKETS 2010 – 2011

REGIONAL MANAGER, SOUTHEAST, JACKSONVILLE FL 2001 – 2003

DIVISION MANAGER, ORGANIC ANALYSIS, KELSO WA 1999 – 2001

BUSINESS DEVELOPMENT MANAGER, KELSO WA 1996 – 1998

PROJECT CHEMIST 1992 – 1996

Proven record of success at increasing levels of responsibility. Managed and directed a multi-division workforce across multiple locations with responsibility (at varying times) for full profit and loss, sales, and sustainable business growth; recruited as a member of the executive team (VP of Sales and Marketing) to help prepare and market the company for a successful sale; reported directly to the Chief Executive Officer (CEO).

Selected Accomplishments

• Responsible for developing business strategy to position the laboratory as a nationally recognized leader in supporting Natural Resource Damage Assessment and Ecological Risk Assessments thereby expanding market share and profit margins to industry leading levels (the flagship laboratory in Kelso, WA consistently led its peer group in revenue per employee and net profits).

• Directed and managed a software development project that streamlined reporting of laboratory data, enabled the lab to efficiently provide customer specific reports, reduced electronic reporting errors, and permitted a 60% increase in gross revenue with no significant increase in labor costs.

• Developed and implemented a national sales program to support six (6) regionally or nationally focused laboratories, provided strategic input to the budgeting process, and ultimately positioned the company for sale by “pitching” a business model to a strategic investor that produced an offer that was 30% higher than other competitive bids. Industries served include environmental remediation/mitigation, pharmaceutical business process outsourcing, and physical/chemical testing of manufactured products and byproducts.

Results

• 150% increase in productivity (revenue per FTE)

• $30MM company valuation

• Top 5 Environmental Laboratory in the US

QUANTUM ANALYTICS, FOSTER CITY, CA 2008 – 2010

The company provides distribution, sales, and financing of highly complex analytical test equipment to commercial, government, and industry labs throughout the United States.

TERRITORY SALES MANAGER, SOUTHEAST

Selected Accomplishments

• Managed sales growth to establish the Southeast as the top performing territory, earning recognition for having transitioned the territory from “worst to first” over an 18 month period.

NOVIDEA, LLC, JACKSONVILLE, FL 2003 – 2008

The company provided sales, quality systems consulting, project management, and consulting to environmental, pharmaceutical, and chemical manufacturing companies throughout the SE United States.

OWNER/OPERATOR

Selected Accomplishments

• Provided project management support of development, validation, verification and roll-out of Laboratory Information Management System to multi-site commercial laboratory.

• Created and managed a distribution channel for a line of gas generators and other laboratory equipment, achieving top tier sales producer for the manufacture.

• Guided multiple commercial and governmental laboratories with the implementation of a quality system to meet National Environmental Laboratory Accreditation Program (NELAP) standards issued by the National Environmental Laboratory Accreditation Conference (NELAC) and modeled on similar ISO standards governing laboratory quality systems.

Selected Publications and Presentations

1. Stability study of opioids and benzodiazepines in urine samples by liquid chromatography tandem mass spectrometry, R.B. Dixon, F. Mbeunkui, J. Wiegel, Journal of Analytical Science and Technology, 2015 6:17.

2. Improved internal control for molecular diagnosis assays, Vinayagamoorthy T., Maryanski D., Vinayagamoorthy D., Hay K.S., Yo J., Carter M., Wiegel J., MethodsX. 2015 Mar 12;2:159-64. doi: 10.1016/j.mex.2015.03.002. eCollection 2015.

3. Detection of BRAF mutations from solid tumors using Tumorplex™ technology. Yo J., Hay K.S., Vinayagamoorthy D., Maryanski D., Carter M., Wiegel J., Vinayagamoorthy T., MethodsX. 2015 Jun 12;2:316-22. doi: 10.1016/j.mex.2015.06.002. eCollection 2015.

4. 2013 AACC Annual Meeting, Houston, TX. Detection and Quantification of Synthetic Cathinones by LC-Triple Quadrupole Mass Spectrometry. F. Mbeunkui, J. Wiegel, R.B. Dixon.

5. 2013 AACC Annual Meeting, Houston, TX. Separation and Quantification of D/L Methamphetamines by Capillary Electrophoresis Triple Quadrupole Mass Spectrometry. F. Mbeunkui, S. Cohen, D. Ponds, J. Wiegel, R.B. Dixon.

6. 61st American Society for Mass Spectrometry Conference 2013, Minneapolis, MN. Rapid Analysis of Synthetic Cathinones (Bath Salts) by Liquid Chromatography Triple Quadrupole Mass Spectrometry, F. Mbeunkui, J. Wiegel, R.B. Dixon.

7. 61st American Society for Mass Spectrometry Conference 2013, Minneapolis, MN. Chiral Analysis and Quantification of D/L-Methamphetamine by Capillary Electrophoresis Triple Quadrupole MS, F. Mbeunkui, S. Cohen, D. Ponds, J. Wiegel, R.B. Dixon.

Contact this candidate